Fluconazole Dosing for Fungal Infections

Introduction to Fluconazole Dosing

The Infectious Diseases Society of America recommends fluconazole for mild oropharyngeal candidiasis is not first-line, with topical agents preferred 1
For moderate to severe oropharyngeal candidiasis, the recommended dose is 200 mg on the first day, followed by 100 mg once daily for 7-14 days, as suggested by the Clinical Infectious Diseases guidelines 2
The American College of Physicians suggests that for esophageal candidiasis, the standard dosing is 200 mg on the first day, followed by 100 mg once daily for 14-21 days, according to the Journal of Microbiology, Immunology and Infection 3
For severe cases of esophageal candidiasis, doses up to 400 mg daily may be used based on clinical response, as recommended by the Clinical Infectious Diseases guidelines 2
The Infectious Diseases Society of America recommends that for fluconazole-refractory disease, alternative antifungals are recommended 2

The Clinical Infectious Diseases guidelines recommend a standard dosing of 400 mg (6 mg/kg) daily for systemic candida infections (candidemia) 2
The optimal duration of treatment is not firmly established but generally continues for 2 weeks after blood cultures become negative and symptoms resolve, as suggested by the Clinical Infectious Diseases guidelines 4
For fluconazole-resistant species, alternative antifungals are recommended, according to the Clinical Infectious Diseases guidelines 2

The Clinical Infectious Diseases guidelines recommend 200 mg (3 mg/kg) daily for 2 weeks for symptomatic cystitis 5
For pyelonephritis, the recommended dose is 200-400 mg (3-6 mg/kg) daily for 2 weeks, as suggested by the Journal of Microbiology, Immunology and Infection and the Clinical Infectious Diseases guidelines 3, 6

The Clinical Infectious Diseases guidelines recommend pediatric dosing of 3 mg/kg ≈ 100 mg in adults 2
For pediatric patients, 6 mg/kg ≈ 200 mg in adults, as recommended by the Clinical Infectious Diseases guidelines 4
The Clinical Infectious Diseases guidelines suggest that growth of Candida from respiratory secretions usually indicates colonization rather than infection and rarely requires antifungal therapy 5
Central venous catheter removal is strongly recommended in cases of candidemia, as suggested by the Clinical Infectious Diseases guidelines 4

The Clinical Infectious Diseases guidelines recommend that fluconazole resistance can develop, particularly in patients with recurrent or chronic infections 2
For fluconazole-resistant Candida species, alternative antifungal agents should be used, according to the Clinical Infectious Diseases guidelines and the Journal of Microbiology, Immunology and Infection 2, 7